Sierra Oncology, Inc. (SRRA) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 90 transactions totaling $70.6M, demonstrating a bullish sentiment with $68.4M in net insider flow. The most recent transaction on Jul 1, 2022 involved a transaction of 5,000 shares valued at $275.0K.
No significant insider buying has been recorded for SRRA in the recent period.
No significant insider selling has been recorded for SRRA in the recent period.
Based on recent SEC filings, insider sentiment for SRRA is bullish with an Insider Alignment Score of 98/100 and a net flow of $68.4M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Sierra Oncology, Inc. (SRRA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading SRRA stock, having executed 90 transactions in the past 90 days. The most active insider is Opportunity, Llc Vivo (Executive), who has made 9 transactions totaling $191.2M.
Get notified when executives and directors at SRRA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 1, 2022 | George Dilly Stephen | Executive | Disposition | 5,000 | $55.00 | $275.0K | |
| Jul 1, 2022 | A. Collard Craig | Executive | Disposition | 13,500 | $55.00 | $742.5K | Large |
| Jul 1, 2022 | R. Allen Andrew | Executive | Disposition | 1,650 | $55.00 | $90.8K | |
| Jul 1, 2022 | Klencke Barbara | Executive | Disposition | 5,000 | $55.00 | $275.0K | |
| Jul 1, 2022 | Klencke Barbara | Executive | Disposition | 10,000 | $55.00 | $550.0K | Large |
| Jul 1, 2022 | Sinclair Andrew | Executive | Disposition | 1,314,127 | $55.00 | $72.3M | Large |
| Jul 1, 2022 | Aggarwal Gaurav | Executive | Disposition | 2,735,853 | $55.00 | $150.5M | Large |
| Jul 1, 2022 | Ashiya Mona | Executive | Disposition | 226,704 | $55.00 | $12.5M | Large |
| Jul 1, 2022 | Ashiya Mona | Executive | Disposition | 1,511,362 | $55.00 | $83.1M | Large |
| Jul 1, 2022 | Ashiya Mona | Executive | Disposition | 226,704 | $55.00 | $12.5M | Large |
| Jul 1, 2022 | Llc Orbimed Capital | Executive | Disposition | 226,704 | $55.00 | $12.5M | Large |
| Jul 1, 2022 | Llc Orbimed Capital | Executive | Disposition | 226,704 | $55.00 | $12.5M | Large |
| Jul 1, 2022 | Llc Orbimed Capital | Executive | Disposition | 1,511,362 | $55.00 | $83.1M | Large |
| Jul 1, 2022 | Llc Vivo Opportunity, | Executive | Disposition | 2,735,853 | $55.00 | $150.5M | Large |
| Jul 1, 2022 | Llc Vivo Opportunity, | Executive | Disposition | 431,947 | $55.00 | $23.8M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Disposition(D) | 16 | $623.9M | 84.0% |
Purchase(P) | 17 | $69.5M | 9.4% |
Exercise (Options)(X) | 14 | $47.8M | 6.4% |
Sale(S) | 10 | $1.1M | 0.1% |
Exercise(M) | 10 | $405.6K | 0.1% |
Other(J) | 13 | $0 | 0.0% |
Conversion(C) | 10 | $0 | 0.0% |
Insiders at Sierra Oncology, Inc. are accumulating shares at an accelerated pace. With 22 insiders making 90 transactions totaling $69.5M in purchases versus $1.1M in sales, the net buying activity of $68.4M signals strong executive confidence. Opportunity, Llc Vivo (Executive) leads the buying activity with $191.2M in transactions across all time.